ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email

Thomas Schinecker, CEO of Roche discusses the company’s weight loss medication pipeline, and explains how the company’s pharmaceutical pricing deal with the U.S. administration will impact their financial strategy.

05:26

Thu, Jan 29 20263:42 AM EST